ApprovalTrail

Approval · Notice of Compliance 5212 · 1995

PROCAINAMIDE: Notice of Compliance 5212

Issued September 12, 1995

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
5212
Date
September 12, 1995
Company
Sabex Inc.Boucherville, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Other
Therapeutic class
Antiarrhythmic

Products in this notice

BrandDINStatus today
PROCAINAMIDE02184486Marketed
PROCAINAMIDE02184494—

Medicinal ingredients